Electrocardiographic changes after neostigmine-atropine mixture

Journal of Anesthesia and Clinical Research

Volumn 3, Issue 2, 2012, Pages

  Lock, Giovani ^a   Fialho, Guilherme Loureiro ^a   Lima, Daniel Castro ^a   Simões Almeida, Maria Cristina ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880030150     PISSN: None     EISSN: 21556148     Source Type: Journal    
DOI: 10.4172/2155-6148.10001     Document Type: Article

References (23)

1. Dhein S, Van koppen CJ, Brodde OE (2001) Muscarinic receptors in the mammalian heart. Pharmacol Res 44: 161-182.
2. Naguib M, Gomaa M (1989) Atropine-neostigmine mixture: a dose-response study. Can J Anaesth 36: 412-417.
3. Food and Drug Administration, HHS (2005) International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice. Fed Regist 70: 61134-61135.
4. Wisely NA, Shipton EA (2002) Long QT syndrome and anaesthesia. Eur J Anaesthesiol19: 853-859.
5. Lorentz MN, Ramiro FG (2007) Anesthesia and the long QT syndrome. Rev Bras Anestesiol 57: 543-548.
6. Soliman EZ, Rautaharju PM (2012) Heart rate adjustment of PR interval in middle-aged and older adults. J Electrocardiol 45: 66-69.
7. Saarnivaara L, Simola M (1998) Effects of four anticholinesteraseanticholinergic combinations and tracheal extubation on QTc interval of the ECG, heart rate and arterial pressure. Acta Anaesthesiol Scand 42: 460-463.
8. Straus SM, Kors JA, De bruin ML, van der Hooft CS, Hofman A, et al. (2006) Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 47: 362-367.
9. Bain WA, Broadbent JL (1949) Death following neostigmine. Br Med J 1: 1137-1138.
10. Clutton-brock J (1949) Death following neostigmine. Br Med J 1: 1007.
11. Hill M (1949) Death after neostigmine injection. Br Med J 2: 601.
12. Macintosh RR (1949) Death following injection of neostigmine. Br Med J 1:852.
13. Beebe DS, Shumway SJ, Maddock R (1994) Sinus arrest after intravenous neostigmine in two heart transplant recipients. Anesth Analg 78: 779-782.
14. Sawasdiwipachai P, Laussen PC, Mcgowan FX, Smoot L, Casta A (2007) Cardiac arrest after neuromuscular blockade reversal in a heart transplant infant. Anesthesiology 107:663-665.
15. Bjerke RJ, Mangione MP (2001) Asystole after intravenous neostigmine in a heart transplant recipient. Can J Anaesth 48: 305-307.
16. Pleym H, Bathen J, Spigset O, Gisvold SE (1999) Ventricular fibrillation related to reversal of the neuromuscular blockade in a patient with long QT syndrome. Acta Anaesthesiol Scand 43: 352-355.
17. Zeidan A, Baraka A (2005) Ventricular fibrillation following atropine-neostigmine mixture in a patient with undiagnosed mitral valve prolapse. Anaesthesia 60:724-725.
18. Kido K, Mizuta K, Mizuta F, Yasuda M, Igari T, et al. (2005) Coronary vasospasm during the reversal of neuromuscular block using neostigmine. Acta Anaesthesiol Scand 49:1395-1396.
19. Liaquat A, Mahmood A (2004) Cardiac arrest following the neuromuscular blockade reversal with neostigmine and atropine. Professional Med J 11: 228-231.
20. Jacobson E, Adelman MH (1954) The electrocardiographic effects of intravenous administration of neostigmine and atropine during cyclopropane anesthesia. Anesthesiology15: 407-415.
21. Gottlieb JD, Sweet RB (1963) The antagonism of curare: the cardiac effects of atropine and neostigmine. Can Anaesth Soc J 10:114-121.
22. Nathan AT, Berkowitz DH, Montenegro LM, Nicolson SC, Vetter VL, et al. (2011) Implications of anesthesia in children with long QT syndrome. Anesth Analg 112:1163-1168.
23. Kopman AF, Eikermann M (2009) Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia 1: 22-30.